InvestorsHub Logo
Followers 13
Posts 1021
Boards Moderated 0
Alias Born 07/19/2013

Re: ejobkar post# 684

Wednesday, 10/02/2019 10:23:32 AM

Wednesday, October 02, 2019 10:23:32 AM

Post# of 878
Awesome! This seems explain Terren's action lately with respect to acquiring huge amount of shares through exercised of warrants. The mere fact that they submitted the Phase 2b/3 protocols in accordance with the FDA guidance, the manufacture of the clinical drug formulation (novel-patent pending IP) batch for this trial, in my opinion have increased BioVie's valuation.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BIVI News